KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Equity Ratio (2016 - 2025)

Historic Equity Ratio for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to 0.02.

  • AbbVie's Equity Ratio fell 14661.38% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 14661.38%. This contributed to the annual value of 0.02 for FY2024, which is 6775.22% down from last year.
  • Latest data reveals that AbbVie reported Equity Ratio of 0.02 as of Q3 2025, which was down 14661.38% from 0.0 recorded in Q2 2025.
  • AbbVie's 5-year Equity Ratio high stood at 0.12 for Q4 2022, and its period low was 0.02 during Q3 2025.
  • Moreover, its 5-year median value for Equity Ratio was 0.09 (2023), whereas its average is 0.07.
  • As far as peak fluctuations go, AbbVie's Equity Ratio skyrocketed by 21222.9% in 2021, and later crashed by 14661.38% in 2025.
  • Quarter analysis of 5 years shows AbbVie's Equity Ratio stood at 0.11 in 2021, then increased by 18.22% to 0.12 in 2022, then tumbled by 38.03% to 0.08 in 2023, then plummeted by 67.75% to 0.02 in 2024, then tumbled by 179.28% to 0.02 in 2025.
  • Its Equity Ratio stands at 0.02 for Q3 2025, versus 0.0 for Q2 2025 and 0.01 for Q1 2025.